SUSTAINED DRUG DELIVERY IMPLANT
    6.
    发明申请

    公开(公告)号:US20210113458A1

    公开(公告)日:2021-04-22

    申请号:US16984971

    申请日:2020-08-04

    申请人: Allergan, Inc.

    摘要: Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine free base to facilitate the release of the brimonidine free base into an eye with the polymer matrix lasts a period of time of not more than twice the drug release duration, but more than the drug release duration.

    Sustained drug delivery implant
    7.
    发明授权

    公开(公告)号:US10231926B2

    公开(公告)日:2019-03-19

    申请号:US15350577

    申请日:2016-11-14

    申请人: Allergan, Inc.

    摘要: Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine free base to facilitate the release of the brimonidine free base into an eye with the polymer matrix lasts a period of time of not more than twice the drug release duration, but more than the drug release duration.